[1]
Foroutan, M. et al. 2019. Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii. EXCLI Journal. 18, (May 2019), 259–272. DOI:https://doi.org/10.17179/excli2018-1993.